COVID-19 Self-testing Study

Columbia University

Status: Completed

Conditions: COVID-19

Treatments: Behavioral: SMARTest mobile app for COVID-19 self-testing

Study type: Interventional

Funder types: Other

Identifiers

NCT05701878

AAAU0815

Details and patient eligibility

About

The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.

Full description

Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management.

The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• English-speaking
• 18 years old or older
• Owns a smartphone running either Android or iOS operating systems
• Willing to download a COVID-19 self-testing app
• Willing to receive and send text messages for the study (and fill out surveys linked from text messages)

Exclusion criteria

• Not willing to self-test themselves with COVID-19 rapid tests

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Intervention (App) Group

Experimental group

Description:

Participants in this group will be given access to a COVID-19 self-testing app (SMARTest). Access to the app, given exclusively to this group, will be in addition to the 12 COVID-19 self-test kits participants receive.

Treatment:

Behavioral: SMARTest mobile app for COVID-19 self-testing

Control (No App) Group

No Intervention group

Description:

Participants in this group will not be given access to the COVID-19 self-testing app (SMARTest). Participants will only receive the 12 COVID-19 self-test kits.